lobbying_activities: 1628229

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1628229	e1bfcabf-7936-4269-bcdb-09419f471d6a	Q4	CAPITOL HILL CONSULTING GROUP	72053	PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	2014	fourth_quarter	PHA	Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2015-01-18T15:59:32.933000-05:00